Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
14
CEG Quote, Financials, Valuation and Earnings
Last price:
$227.00
Seasonality move
:
14.61%
Day range:
$219.64 - $231.70
52-week range:
$109.44 - $288.75
Dividend yield:
0.62%
P/E ratio:
25.03x
P/S ratio:
3.00x
P/B ratio:
5.65x
Volume:
5M
Avg. volume:
2.8M
1-year change:
94.02%
Market cap:
$71B
Revenue:
$24.9B
EPS (TTM):
$9.07
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $18.9B | $17.6B | $19.6B | $24.4B | $24.9B | |
| Revenue Growth (YoY) | -7.4% | -6.98% | 11.62% | 24.38% | 1.96% | |
| Cost of Revenues | $15.6B | $14.8B | $16.7B | $22.3B | $21.7B | |
| Gross Profit | $3.4B | $2.9B | $2.9B | $2.1B | $3.2B | |
| Gross Profit Margin | 17.7% | 16.19% | 14.92% | 8.74% | 12.97% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | $1.1B | $678M | $87M | $166M | $473M | |
| Operating Expenses | $2.1B | $2.4B | $2.6B | $2.6B | $827M | |
| Operating Income | $1.3B | $425M | $362M | -$457M | $2.4B | |
| Net Interest Expenses | $429M | $267M | $297M | $251M | $431M | |
| EBT. Incl. Unusual Items | $1.9B | $836M | $152M | -$542M | $2.4B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $516M | $249M | $225M | -$388M | $859M | |
| Net Income to Company | $1.2B | $579M | -$83M | -$167M | $1.6B | |
| Minority Interest in Earnings | -$92M | $10M | -$122M | $7M | $46M | |
| Net Income to Common Excl Extra Items | $1.1B | $589M | -$205M | -$160M | $1.6B | |
| Basic EPS (Cont. Ops) | $3.45 | $1.81 | -$0.63 | -$0.49 | $5.02 | |
| Diluted EPS (Cont. Ops) | $3.45 | $1.81 | -$0.63 | -$0.49 | $5.01 | |
| Weighted Average Basic Share | $326.3M | $326.3M | $326M | $328M | $323M | |
| Weighted Average Diluted Share | $326.3M | $326.3M | $326M | $329M | $324M | |
| EBITDA | $5.4B | $4.8B | $4.4B | $1.6B | $4.8B | |
| EBIT | $2.3B | $1.2B | $449M | -$291M | $2.9B | |
| Revenue (Reported) | $18.9B | $17.6B | $19.6B | $24.4B | $24.9B | |
| Operating Income (Reported) | $1.3B | $425M | $362M | -$457M | $2.4B | |
| Operating Income (Adjusted) | $2.3B | $1.2B | $449M | -$291M | $2.9B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | $4.4B | $6.1B | $6.1B | $6.6B | |
| Revenue Growth (YoY) | -- | -- | 37.34% | 0.99% | 7.18% | |
| Cost of Revenues | -- | $2.5B | $5.7B | $4.7B | $4.7B | |
| Gross Profit | -- | $1.9B | $367M | $1.4B | $1.9B | |
| Gross Profit Margin | -- | 43.62% | 6.07% | 22.76% | 28.95% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -$87M | $50M | $109M | -$88M | |
| Operating Expenses | -- | $970M | $654M | $523M | $16M | |
| Operating Income | -- | $952M | -$287M | $868M | $1.9B | |
| Net Interest Expenses | -- | $51M | $75M | $82M | $147M | |
| EBT. Incl. Unusual Items | -- | $814M | -$312M | $895M | $1.6B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | $177M | -$123M | $205M | $449M | |
| Net Income to Company | -- | $634M | -$193M | $690M | $1.2B | |
| Minority Interest in Earnings | -- | -$26M | $5M | $41M | $4M | |
| Net Income to Common Excl Extra Items | -- | $607M | -$188M | $731M | $1.2B | |
| Basic EPS (Cont. Ops) | -- | $1.86 | -$0.57 | $2.27 | $3.83 | |
| Diluted EPS (Cont. Ops) | -- | $1.86 | -$0.57 | $2.26 | $3.82 | |
| Weighted Average Basic Share | -- | $326.3M | $327M | $322M | $313M | |
| Weighted Average Diluted Share | -- | $326.3M | $328M | $323M | $314M | |
| EBITDA | -- | $1.8B | $25M | $1.4B | $2.3B | |
| EBIT | -- | $891M | -$237M | $977M | $1.8B | |
| Revenue (Reported) | -- | $4.4B | $6.1B | $6.1B | $6.6B | |
| Operating Income (Reported) | -- | $952M | -$287M | $868M | $1.9B | |
| Operating Income (Adjusted) | -- | $891M | -$237M | $977M | $1.8B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | $18.4B | $22.6B | $26.5B | $24B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | $15.1B | $20.4B | $23.3B | $18.9B | |
| Gross Profit | -- | $3.3B | $2.2B | $3.1B | $5B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | $949M | -$1.1B | $1.5B | $511M | |
| Operating Expenses | -- | $3.8B | $1.4B | $1.8B | $1.2B | |
| Operating Income | -- | -$511M | $828M | $1.3B | $3.8B | |
| Net Interest Expenses | -- | $143M | $284M | $356M | $555M | |
| EBT. Incl. Unusual Items | -- | $295M | -$529M | $2.5B | $3.8B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | $316M | -$387M | $794M | $950M | |
| Net Income to Company | -- | -- | -$156M | $1.6B | $2.8B | |
| Minority Interest in Earnings | -- | -$199M | $5M | $50M | $11M | |
| Net Income to Common Excl Extra Items | -- | -$228M | -$151M | $1.7B | $2.9B | |
| Basic EPS (Cont. Ops) | -- | -$0.70 | -$0.46 | $5.23 | $9.09 | |
| Diluted EPS (Cont. Ops) | -- | -$0.70 | -$0.46 | $5.21 | $9.07 | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | -- | $5.5B | $1.6B | $4.7B | $6.4B | |
| EBIT | -- | $600M | -$270M | $2.8B | $4.4B | |
| Revenue (Reported) | -- | $18.4B | $22.6B | $26.5B | $24B | |
| Operating Income (Reported) | -- | -$511M | $828M | $1.3B | $3.8B | |
| Operating Income (Adjusted) | -- | $600M | -$270M | $2.8B | $4.4B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | $14.1B | $17.1B | $19.1B | $18.2B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | $11.5B | $15.2B | $16.2B | $13.5B | |
| Gross Profit | -- | $2.6B | $1.9B | $2.9B | $4.7B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -$14M | $2M | |
| Other Inc / (Exp) | -- | $482M | -$678M | $1.5B | $657M | |
| Operating Expenses | -- | $2.9B | $1.8B | $1.8B | $1.3B | |
| Operating Income | -- | -$338M | $128M | $1.1B | $3.4B | |
| Net Interest Expenses | -- | $153M | $139M | $292M | $416M | |
| EBT. Incl. Unusual Items | -- | -$9M | -$689M | $2.3B | $3.7B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | $108M | -$504M | $678M | $768M | |
| Net Income to Company | -- | -$122M | -$195M | $1.6B | $2.9B | |
| Minority Interest in Earnings | -- | -$124M | $2M | $44M | $9M | |
| Net Income to Common Excl Extra Items | -- | -$247M | -$193M | $1.7B | $2.9B | |
| Basic EPS (Cont. Ops) | -- | -$0.76 | -$0.59 | $5.13 | $9.20 | |
| Diluted EPS (Cont. Ops) | -- | -$0.76 | -$0.59 | $5.11 | $9.18 | |
| Weighted Average Basic Share | -- | $978.9M | $981M | $974M | $945M | |
| Weighted Average Diluted Share | -- | $978.9M | $984M | $976M | $948M | |
| EBITDA | -- | $3.8B | $967M | $4B | $5.6B | |
| EBIT | -- | $216M | -$502M | $2.6B | $4.1B | |
| Revenue (Reported) | -- | $14.1B | $17.1B | $19.1B | $18.2B | |
| Operating Income (Reported) | -- | -$338M | $128M | $1.1B | $3.4B | |
| Operating Income (Adjusted) | -- | $216M | -$502M | $2.6B | $4.1B | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $303M | $226M | $504M | $422M | $368M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $2.9B | $1.3B | $1.7B | $2.6B | $1.9B | |
| Inventory | $1.3B | $1.2B | $1.3B | $1.5B | $1.5B | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $941M | $2B | $1.5B | $1.6B | $2.3B | |
| Total Current Assets | $7.1B | $6.9B | $8B | $9.4B | $8.3B | |
| Property Plant And Equipment | $24.2B | $22.2B | $19.6B | $19.8B | $22.1B | |
| Long-Term Investments | $235M | $184M | $174M | $202M | $563M | |
| Goodwill | $47M | -- | -- | $47M | $425M | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $15.2B | $16.6B | $17.7B | $16.2B | $18.3B | |
| Total Assets | $49B | $48.1B | $48.1B | $46.9B | $50.8B | |
| Accounts Payable | $1.7B | $1.3B | $1.8B | -- | -- | |
| Accrued Expenses | $786M | $788M | $737M | -- | -- | |
| Current Portion Of Long-Term Debt | $3.5B | $1.3B | $3.3B | $1.3B | $1.8B | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | $1.2B | $1.7B | $2.1B | $2.8B | $1.9B | |
| Total Current Liabilities | $7.3B | $5.2B | $8B | $7.8B | $6.3B | |
| Long-Term Debt | $4.8B | $5.9B | $4.9B | $4.5B | $7.5B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $33.2B | $33.4B | $36.5B | $35.5B | $39.5B | |
| Common Stock | -- | -- | -- | $13.3B | $12.4B | |
| Other Common Equity Adj | -$32M | -$30M | -$31M | -$1.8B | -$2.2B | |
| Common Equity | $13.5B | $12.4B | $11.2B | $11B | $10.9B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $2.3B | $2.3B | $395M | $354M | $361M | |
| Total Equity | $15.8B | $14.7B | $11.6B | $11.4B | $11.3B | |
| Total Liabilities and Equity | $49B | $48.1B | $48.1B | $46.9B | $50.8B | |
| Cash and Short Terms | $303M | $226M | $504M | $422M | $368M | |
| Total Debt | $8.3B | $7.2B | $8.2B | $5.8B | $9.3B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | -- | $2B | $1.2B | $1.9B | $1.8B | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | $1.3B | $1.8B | $1.5B | $1.2B | |
| Inventory | -- | $1.2B | $1.5B | $1.4B | $1.5B | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | $1.8B | $2.1B | $2.8B | $3.5B | |
| Total Current Assets | -- | $8.6B | $9.9B | $9.9B | $9.3B | |
| Property Plant And Equipment | -- | $19.6B | $19.7B | $20.8B | $20.9B | |
| Long-Term Investments | -- | $165M | $193M | $727M | $494M | |
| Goodwill | -- | $47M | -- | -- | $420M | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | $17B | $15.6B | $16.5B | $20B | |
| Total Assets | -- | $48B | $46.6B | $49B | $51.8B | |
| Accounts Payable | -- | $1.6B | $2.6B | -- | -- | |
| Accrued Expenses | -- | $691M | $933M | -- | -- | |
| Current Portion Of Long-Term Debt | -- | $2.6B | $874M | $643M | $1B | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | $2.7B | $3.5B | $2.4B | $1.7B | |
| Total Current Liabilities | -- | $7.8B | $7.9B | $5.3B | $5.5B | |
| Long-Term Debt | -- | $4.9B | $4.5B | $7.5B | $7.4B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | $36B | $35.4B | $37B | $38.9B | |
| Common Stock | -- | -- | $13.3B | $12.6B | $11.4B | |
| Other Common Equity Adj | -- | -$31M | -$2B | -$1.8B | -$2.1B | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | $401M | $366M | $334M | $371M | |
| Total Equity | -- | $12B | $11.2B | $12B | $12.9B | |
| Total Liabilities and Equity | -- | $48B | $46.6B | $49B | $51.8B | |
| Cash and Short Terms | -- | $2B | $1.2B | $1.9B | $1.8B | |
| Total Debt | -- | $7.5B | $5.4B | $8.2B | $8.4B | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $1.2B | $579M | -$83M | -$167M | $1.6B | |
| Depreciation & Amoritzation | $3.1B | $3.6B | $4B | $1.8B | $1.9B | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$186M | $1.1B | -$616M | -$868M | $396M | |
| Change in Inventories | -$47M | -$77M | -$68M | -$228M | $60M | |
| Cash From Operations | $2.9B | $584M | -$1.3B | -$2.4B | -$5.3B | |
| Capital Expenditures | $1.8B | $1.7B | $1.3B | $1.7B | $2.4B | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$1.9B | $2B | $3.3B | $3.1B | $3B | |
| Dividends Paid (Ex Special Dividend) | -$899M | -$1.7B | -$1.8B | -$185M | -$366M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $362M | $3.7B | $1.4B | $271M | $3.9B | |
| Long-Term Debt Repaid | -$813M | -$4.9B | -$105M | -$2.6B | -$368M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -$992M | |
| Other Financing Activities | -$110M | $279M | -$1.2B | $1.7B | $42M | |
| Cash From Financing | -$1.5B | -$2.7B | -$1.7B | -$799M | $2.2B | |
| Beginning Cash (CF) | $903M | $449M | $327M | $576M | $528M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$454M | -$122M | $249M | -$48M | -$74M | |
| Ending Cash (CF) | $449M | $327M | $576M | $528M | $454M | |
| Levered Free Cash Flow | $1B | -$1.2B | -$2.7B | -$4B | -$7.7B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | $634M | -$193M | $690M | $1.2B | |
| Depreciation & Amoritzation | -- | $859M | $172M | $466M | $489M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -$117M | -$210M | -$356M | $312M | |
| Change in Inventories | -- | -$33M | -$78M | -$34M | -$27M | |
| Cash From Operations | -- | $1.3B | -$1.2B | -$993M | -$112M | |
| Capital Expenditures | -- | $367M | $290M | $399M | $552M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | $533M | $1.2B | $2B | $2.4B | |
| Dividends Paid (Ex Special Dividend) | -- | -$457M | -$46M | -$92M | -$111M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | $881M | $3M | $1.4B | -- | |
| Long-Term Debt Repaid | -- | -$33M | $459M | -$464M | -$714M | |
| Repurchase of Common Stock | -- | -- | -- | -$251M | -- | |
| Other Financing Activities | -- | -$837M | -$15M | $16M | $30M | |
| Cash From Financing | -- | -$446M | $401M | $637M | -$795M | |
| Beginning Cash (CF) | -- | $601M | $926M | $325M | $383M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | $1.4B | $377M | $1.7B | $1.5B | |
| Ending Cash (CF) | -- | $2B | $1.3B | $2B | $1.9B | |
| Levered Free Cash Flow | -- | $964M | -$1.5B | -$1.4B | -$664M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -$156M | $1.6B | $2.8B | |
| Depreciation & Amoritzation | -- | -- | $1.8B | $1.9B | $2B | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -$559M | $224M | $537M | |
| Change in Inventories | -- | -- | -$205M | $28M | $1M | |
| Cash From Operations | -- | -- | -$2.2B | -$4.5B | -$4.6B | |
| Capital Expenditures | -- | $1.1B | $1.3B | $2.3B | $2.5B | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | $2.5B | $3.4B | $5.9B | |
| Dividends Paid (Ex Special Dividend) | -- | -$1.4B | -$598M | -$323M | -$422M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | $371M | $4B | $1.3B | |
| Long-Term Debt Repaid | -- | -- | -$2.5B | -$1.1B | -$1B | |
| Repurchase of Common Stock | -- | -- | -- | -$750M | -$1.2B | |
| Other Financing Activities | -- | -- | $1.7B | $14M | $31M | |
| Cash From Financing | -- | -- | -$987M | $1.8B | -$1.4B | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -$716M | $674M | -$95M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -$3.6B | -$6.9B | -$7.2B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -$122M | -$195M | $1.6B | $2.9B | |
| Depreciation & Amoritzation | -- | $3.5B | $1.4B | $1.4B | $1.5B | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -$207M | -$150M | $942M | $1.1B | |
| Change in Inventories | -- | -$29M | -$166M | $90M | $31M | |
| Cash From Operations | -- | $974M | $69M | -$2.1B | -$1.4B | |
| Capital Expenditures | -- | $1.1B | $1.1B | $1.7B | $1.8B | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | $2.6B | $1.9B | $2.2B | $5.1B | |
| Dividends Paid (Ex Special Dividend) | -- | -$1.4B | -$139M | -$277M | -$333M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | $1B | $9M | $3.7B | $1.1B | |
| Long-Term Debt Repaid | -- | -$429M | -$2.8B | -$1.3B | -$1.9B | |
| Repurchase of Common Stock | -- | -- | -- | -$750M | -$999M | |
| Other Financing Activities | -- | -$1.2B | $1.7B | $6M | -$5M | |
| Cash From Financing | -- | -$1.9B | -$1.2B | $1.4B | -$2.2B | |
| Beginning Cash (CF) | -- | $1.7B | $3.2B | $1.2B | $1.5B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | $1.7B | $727M | $1.4B | $1.4B | |
| Ending Cash (CF) | -- | $3.4B | $3.9B | $2.6B | $2.9B | |
| Levered Free Cash Flow | -- | -$112M | -$1B | -$3.9B | -$3.3B | |
Get CEG Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
CEG
Sector
P/E ratio
25.03x
14.18x
PEG ratio
0.34x
0.36x
P/B ratio
5.65x
1.35x
Price / LTM sales
3.00x
1.60x
Growth Metrics
CEG
Sector
Revenue growth
7.18%
1.13%
Earnings growth
69.03%
2.03%
Revenue (5-year growth)
4.05%
4.99%
Earnings forecast
$2.68
$0.43
Profitability
CEG
Sector
Profitability FY 2023
$3.2B
$1.5B
Return on invested capital
13.68%
3.64%
Return on assets
5.61%
2.58%
Return on equity
24.01%
8.33%
Earnings Date
Last Earnings Date
Nov
4
Next Earnings Date
Feb
27
Estimated Next Earnings Date
Feb
3
Balance Sheet
CEG
Sector
Total cash
$1.8B
$441.3M
Short term investments
--
$145.7M
Total assets
$50.8B
$12.3B
Long term debt
$8.4B
$3.3B
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
